Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

STAAR Surgical to Participate in Upcoming Investor Conferences

BusinessWire_EN 
0 0 02.09.20
STAAR Surgical to Participate in Upcoming Investor Conferences
 

STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today announced that management will participate in several upcoming investor conferences. The Company has issued an updated investor presentation it will use during the upcoming meetings, which is available on the Company’s investor website at investors.staar.com.

Caren Mason, President & CEO, and Patrick F. Williams, CFO, will participate in the following investor conferences during the month of September:

  • William Blair West Coast Field Trip 2020, Wednesday, September 2
  • Wells Fargo 2020 Virtual Healthcare Conference, Wednesday, September 9
  • Morgan Stanley 18th Annual Global Healthcare Conference, Monday, September 14
  • Sidoti & Co. Small Cap Virtual Investor Conference, Thursday, September 24

Attendance at the investor conferences is by invitation only from each sponsoring research brokerage firm. Please contact the brokerage firm directly for more information.

About STAAR Surgical

STAAR, which has been dedicated solely to ophthalmic surgery for over 30 years, designs, develops, manufactures and markets implantable lenses for the eye with companion delivery systems. These lenses are intended to provide visual freedom for patients, lessening or eliminating the reliance on glasses or contact lenses. All of these lenses are foldable, which permits the surgeon to insert them through a small incision. STAAR’s lens used in refractive surgery is called an Implantable Collamer® Lens or “ICL”, which includes the EVO Visian ICL™ product line. More than 1,000,000 Visian® ICLs have been implanted to date and STAAR markets these lenses in over 75 countries. To learn more about the ICL go to: www.discovericl.com. Headquartered in Lake Forest, CA, the company operates manufacturing and packaging facilities in Aliso Viejo, CA, Monrovia, CA and Nidau, Switzerland. For more information, please visit the Company’s website at www.staar.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20200902005311/en/

Staar Surgical Co. Stock

€29.30
-2.190%
We can see a decrease in the price for Staar Surgical Co.. Compared to yesterday it has lost -€0.650 (-2.190%).
With 13 Buy predictions and only 1 Sell predictions the community sentiment for the stock is positive.
With a target price of 47 € there is a hugely positive potential of 60.41% for Staar Surgical Co. compared to the current price of 29.3 €.
Show more
Like: 0
Share
BusinessWire_EN 
Business Wire, a Berkshire Hathaway company, is the global leader in press release distribution and regulatory disclosure. Investor relations, public relations, public policy and marketing professionals rely on Business Wire for secure and accurate distribution of market-moving news and multimedia.

Legal notice

Comments

Not a member yet? Sign up for free!